Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ABI-007 vs Docetaxel in Metastatic Breast Cancer
NCT00274456Phase 2Completed
- Sponsor
- Celgene Corporation
- Start
- Nov 2005
- Primary completion
- Mar 2008
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nab-paclitaxel in breast cancer, sponsored by Celgene Corporation. Started Nov 2005; status: completed.
02
Drugs
nab-paclitaxel
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00274456.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00274456.